Consolidated Balance Sheets Statement - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 16,665	$ 22,494
Accounts receivable, net of allowance for doubtful accounts of $3,240 and $4,136 at 2016 and 2015, respectively	122,496	145,689
Inventories	41,702	40,906
Prepaid expenses	12,191	12,053
Income taxes receivable	7,711	7,209
Other current assets	6,645	10,196
TOTAL CURRENT ASSETS	207,410	238,547
PROPERTY, PLANT AND EQUIPMENT, net	138,860	143,211
INTANGIBLES, net	9,857	10,041
GOODWILL	178,159	178,159
DEFERRED TAX ASSETS, net	9,178	11,693
OTHER ASSETS	43,786	43,607
TOTAL ASSETS	587,250	625,258
CURRENT LIABILITIES:
Accounts payable	34,753	33,474
Accrued payroll and related costs	34,756	36,475
Taxes other than payroll and income	7,937	9,495
Unearned revenue	14,272	14,101
Income taxes payable	4,310	1,733
Other current liabilities	12,388	25,480
TOTAL CURRENT LIABILITIES	108,416	120,758
LONG-TERM DEBT, net	407,112	430,987
DEFERRED COMPENSATION	42,598	43,478
DEFERRED TAX LIABILITIES, net	7,983	4,881
OTHER LONG-TERM LIABILITIES	$ 49,123	$ 48,853
COMMITMENTS AND CONTINGENCIES (Note 6)
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	$ 0	$ 0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,350,002 issued and 42,391,696 outstanding at 2016 and 44,350,002 issued and 42,375,905 outstanding at 2015	1,142	1,142
Additional paid-in capital	2,356	0
Retained earnings	210,983	219,207
Accumulated other comprehensive income (loss)	(11,330)	(10,538)
Treasury shares (at cost), 1,958,306 at 2016 and 1,974,097 at 2015	(236,533)	(238,875)
Total Core Laboratories N.V. shareholders' equity (deficit)	(33,382)	(29,064)
Non-controlling interest	5,400	5,365
TOTAL EQUITY (DEFICIT)	(27,982)	(23,699)
TOTAL LIABILITIES AND EQUITY (DEFICIT)	$ 587,250	$ 625,258